Charles River
Contract research news in brief
November 12, 2012Research and Development Bay Bioanalytical Laboratory, Bioclinica, Charles River, ICON, Pacific BioLabs, Quintiles, Vital River
Acquisitions for Charles River and Pacific BioLabs, a new contract for Bioclinica plus updates from Icon and Quintiles.
Contract research news in brief
September 4, 2012Research and Development CRO, Charles River, WuXi
Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …
WuXi posts buoyant increases in revenue and profit
May 13, 2010Research and Development CRO, Charles River, Charles River Laboratories, WuXi
China’s WuXi PharmaTech has given would-be purchaser Charles River Laboratories a lift after posting buoyant increases in both revenues and …
Charles River to buy WuXi for $1.6bn
April 27, 2010Research and Development Charles River, Charles River Laboratories, WuXi, contract research
Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …
Charles River cuts forecasts as profits slump
August 11, 2009Research and Development Charles River, preclinical
Contract preclinical testing specialist Charles River Laboratories saw its second-quarter sales drop 12.5% to $308 million as demand from pharmaceutical …
Charles River restructures as president sets retirement date
July 14, 2009Research and Development CRO, Charles River
Charles River Laboratories has unveiled a major shake-up its business and sales activities as part of a reorganisation prompted by …
Quotient buys Scottish clinical unit from Charles River
May 26, 2009Research and Development Charles River, Quotient
Contract research organisation Quotient Bioresearch has acquired a facility from Charles River Laboratories that will boost its capabilities in the …
Latest content
FibroFind appoints Lee Borthwick as CEO
